기관지내 초음파 생검 시장 규모, 점유율 및 동향 분석 보고서 : 제품별, 시술별, 최종 용도별, 지역별 및 부문별 예측(2026-2033년)

Endobronchial Ultrasound Biopsy Market Summary

The global endobronchial ultrasound biopsy market size was estimated at USD 141.68 million in 2025 and is projected to reach USD 214.39 million by 2033, growing at a CAGR of 5.25% from 2026 to 2033. This growth can be attributed to the rising prevalence of cancer, increasing technological advancements in endobronchial ultrasound (EBUS) technology, the growing geriatric population, the growing prevalence of respiratory diseases, and the increasing adoption of minimally invasive procedures.

According to the WHO, the global elderly population aged 60 years and above is expected to increase from around 1.1 billion in 2021 to 1.4 billion in 2030.

Global Endobronchial Ultrasound Biopsy Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global endobronchial ultrasound biopsymarket report based on product, procedure, end use, and region.

• Product Outlook (Revenue in USD Million, Annual Equipment Sale, Installed Base, 2021 - 2033)
• Product Equipment
  • EBUS Scopes
  • Convex (CP-EBUS Scope)
  • Radial (RP-EBUS Probe)
  • Ultrasound Processors and Imaging Systems
• Product Consumables
  • EBUS-TBNA Needles
  • EBUS-Related Bronchoscopic Procedure Consumables and Accessories
  • Biopsy Forceps
  • Cytology Brushes
  • Cryoprobes
  • Guide Sheaths
  • Accessories (Disposable Suction and Biopsy Valves, Specimen Traps and Collection Accessories, Other Procedure Accessories, etc.)
• Procedure Outlook (Number of Procedures in Thousand, 2021 - 2033)
• EBUS Scopes
  • Convex-probe (Linear / CP-EBUS) Scopes
  • By Indication
  • Lung Cancer Staging
  • Sarcoidosis/Others
• Radial-probe (RP-EBUS) Scopes
• End Use Outlook (Revenue in USD Million, 2021 - 2033)
• Hospitals
  • Community Hospitals
  • Academic/Teaching Hospitals
  • Large Multispecialty Hospitals/Networks
• Ambulatory Surgical Centers (ASCs)
  • Independent ASCs
  • Hospital-Affiliated ASCs
• Specialty Clinics
• Regional Outlook (Revenue in USD Million, Annual Equipment Sale, Installed Base, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Thailand
• Latin America
  • Brazil
  • Argentina
• Middle East and Africa (MEA)
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Segment Definition
  • 1.3.1. Product Segment
  • 1.3.2. Procedure Segment
  • 1.3.3. End Use Segment
  • 1.3.4. 1.3 Regional Scope
• 1.4. Estimates And Forecast Timeline
• 1.5. Objectives
  • 1.5.1. OBJECTIVE - 1
  • 1.5.2. OBJECTIVE - 2
  • 1.5.3. OBJECTIVE - 3
• 1.6. Research Methodology: Model Details
  • 1.6.1. Procedure Side Market
    • 1.6.1.1. Overall number of EBUS procedures performed
      • 1.6.1.1.1.Convex / Linear EBUS (CP-EBUS) Procedure Volume Estimation
      • 1.6.1.1.2.Radial Probe EBUS (RP-EBUS) Procedure Volume Model
  • 1.6.2. Product Side Market
    • 1.6.2.1. Equipment Installed Base Analysis
    • 1.6.2.2. Linear EBUS (CP-EBUS)
    • 1.6.2.3. Radial Probe EBUS (RP-EBUS)
    • 1.6.2.4. Ultrasound Processors & Imaging Systems
    • 1.6.2.5. Consumables (EBUS-TBNA Needles + EBUS-Related Bronchoscopic Procedure Consumables and Accessories)
  • 1.6.3. Comprehensive Research Methodology
    • 1.6.3.1. Commodity Flow Analysis
• 1.7. Endobronchial Ultrasound (EBUS) Biopsy Market: CAGR Calculation
• 1.8. Primary Research Methodology
• 1.9. List of Secondary Sources
• 1.10. List of Abbreviation

Chapter 2. Executive Summary

• 2.1. Market Snapshot
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Rising incidence of lung cancer and respiratory disorders
    • 3.2.1.2. Increased innovation in EBUS bronchoscopes and strengthening market leadership
    • 3.2.1.3. Shift toward minimally invasive diagnostics
    • 3.2.1.4. Favorable reimbursement and clinical guidelines
    • 3.2.1.5. Government-led lung cancer screening programs
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. The high cost of EBUS systems and associated procedures
    • 3.2.2.2. Requirement for highly skilled professionals
  • 3.2.3. Industry Opportunity Analysis
  • 3.2.4. Industry Challenge Analysis
• 3.3. Case Studies
• 3.4. Business Environment Analysis
  • 3.4.1. Porter's Five Forces Analysis
    • 3.4.1.1. Supplier power
    • 3.4.1.2. Buyer power
    • 3.4.1.3. Substitution threat
    • 3.4.1.4. Threat of new entrant
    • 3.4.1.5. Competitive rivalry
  • 3.4.2. PESTLE Analysis
    • 3.4.2.1. Political landscape
    • 3.4.2.2. Economic and Social landscape
    • 3.4.2.3. Technological landscape
    • 3.4.2.4. Environmental landscape
    • 3.4.2.5. Legal Landscape

Chapter 4. Endobronchial Ultrasound Biopsy Market: Product Estimates & Trend Analysis

• 4.1. Product Segment Dashboard
• 4.2. Product Market Share Movement Analysis, 2025 & 2033
• 4.3. Market Size & Forecasts and Trend Analysis, by Product, 2021 to 2033 (USD Million)
• 4.4. Product Equipment
  • 4.4.1. EBUS Scopes
    • 4.4.1.1. Convex (CP-EBUS Scope)
      • 4.4.1.1.1.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.4.1.1.1.2. Market Annual Equipment Sale Estimates and Forecasts, 2021 - 2033
      • 4.4.1.1.1.3. Market Installed Base Estimates and Forecasts, 2021 - 2033
    • 4.4.1.2. Radial (CP-EBUS Probe)
      • 4.4.1.2.1.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.4.1.2.1.2. Market Annual Equipment Sale Estimates and Forecasts, 2021 - 2033
      • 4.4.1.2.1.3. Market Installed Base Estimates and Forecasts, 2021 - 2033
  • 4.4.2. Ultrasound Processors and Imaging Systems
    • 4.4.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.2.2. Market Annual Equipment Sale Estimates and Forecasts, 2021 - 2033
    • 4.4.2.3. Market Installed Base Estimates and Forecasts, 2021 - 2033
• 4.5. Product Consumables
  • 4.5.1. EBUS-TBNA Needles
    • 4.5.1.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.5.1.2. Market Estimates and Forecasts, 2021 - 2033 (000' Units)
  • 4.5.2. EBUS-Related Bronchoscopic Procedure Consumables and Accessories
    • 4.5.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.5.2.2. Market Estimates and Forecasts, 2021 - 2033 (000' Units)
  • 4.5.3. Biopsy Forceps
    • 4.5.3.1.1.Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.5.3.1.2.Market Estimates and Forecasts, 2021 - 2033 (000' Units)
    • 4.5.3.2. Cytology Brushes
      • 4.5.3.2.1.Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.5.3.2.2.Market Estimates and Forecasts, 2021 - 2033 (000' Units)
    • 4.5.3.3. Cryoprobes
      • 4.5.3.3.1.Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.5.3.3.2.Market Estimates and Forecasts, 2021 - 2033 (000' Units)
    • 4.5.3.4. Guide Sheaths
      • 4.5.3.4.1.Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.5.3.4.2.Market Estimates and Forecasts, 2021 - 2033 (000' Units)
    • 4.5.3.5. Accessories (Disposable Suction and Biopsy Valves, Specimen Traps and Collection Accessories, Other Procedure Accessories, etc.)
      • 4.5.3.5.1.Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.5.3.5.2.Market Estimates and Forecasts, 2021 - 2033 (000' Units)

Chapter 5. Endobronchial Ultrasound Biopsy Market: Procedure Estimates & Trend Analysis

• 5.1. Procedure Dashboard
• 5.2. Procedure Market Share Movement Analysis, 2025 & 2033
• 5.3. Market Estimates & Forecasts and Trend Analysis, by Procedure, 2021 to 2033 (in '000 Procedures)
• 5.4. EBUS Scopes
  • 5.4.1. Procedure Volume Estimates & Forecasts, 2021 - 2033 (in '000 Procedures)
  • 5.4.2. Convex-probe (Linear / CP-EBUS) Scopes
    • 5.4.2.1. Procedure Volume Estimates & Forecasts, 2021 - 2033 (in '000 Procedures)
    • 5.4.2.2. Lung Cancer Staging
      • 5.4.2.2.1.Procedure Volume Estimates & Forecasts, 2021 - 2033 (in '000 Procedures)
    • 5.4.2.3. Sarcoidosis/Others
      • 5.4.2.3.1.Procedure Volume Estimates & Forecasts, 2021 - 2033 (in '000 Procedures)
  • 5.4.3. Radial-probe (RP-EBUS) Scopes
    • 5.4.3.1. Procedure Volume Estimates & Forecasts, 2021 - 2033 (in '000 Procedures)

Chapter 6. Endobronchial Ultrasound Biopsy Market: End Use Estimates & Trend Analysis

• 6.1. End Use Segment Dashboard
• 6.2. End Use Market Share Movement Analysis, 2025 & 2033
• 6.3. Market Size & Forecasts and Trend Analysis, by End Use, 2021 to 2033 (USD Million)
• 6.4. Hospitals
  • 6.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.4.2. Community Hospitals (Typically 100-300 beds, serving local/regional populations.)
    • 6.4.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.4.3. Academic/Teaching Hospitals [500+ beds, often part of academic medical networks.
    • 6.4.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.4.4. Large Multispecialty Hospitals/Networks (300-500+ beds, often part of integrated delivery networks (IDNs))
    • 6.4.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.5. Ambulatory Surgical Centers (ASCs)
  • 6.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5.2. Independent ASCs
    • 6.5.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5.3. Hospital-Affiliated ASCs
    • 6.5.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.6. Specialty Clinics
  • 6.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Endobronchial Ultrasound Biopsy Market: Regional Estimates & Trend Analysis

• 7.1. Regional Market Dashboard
• 7.2. Regional Market: Key Takeaways
• 7.3. North America
  • 7.3.1. North America Endobronchial ultrasound biopsy market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.3.2. U.S.
    • 7.3.2.1. Key country dynamic
    • 7.3.2.2. Regulatory framework
    • 7.3.2.3. Competitive insights
    • 7.3.2.4. U.S. Endobronchial ultrasound biopsy market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.3.3. Canada
    • 7.3.3.1. Key country dynamic
    • 7.3.3.2. Regulatory framework
    • 7.3.3.3. Competitive insights
    • 7.3.3.4. Canada Endobronchial ultrasound biopsy market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.3.4. Mexico
    • 7.3.4.1. Key country dynamic
    • 7.3.4.2. Regulatory framework
    • 7.3.4.3. Competitive insights
    • 7.3.4.4. Mexico Endobronchial ultrasound biopsy market estimates and forecasts, 2021 - 2033 (USD Million)
• 7.4. Europe
  • 7.4.1. Europe Endobronchial ultrasound biopsy market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.4.2. Germany
    • 7.4.2.1. Key country dynamic
    • 7.4.2.2. Regulatory framework
    • 7.4.2.3. Competitive insights
    • 7.4.2.4. Germany Endobronchial ultrasound biopsy market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.4.3. UK
    • 7.4.3.1. Key country dynamic
    • 7.4.3.2. Regulatory framework
    • 7.4.3.3. Competitive insights
    • 7.4.3.4. UK Endobronchial ultrasound biopsy market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.4.4. France
    • 7.4.4.1. Key country dynamic
    • 7.4.4.2. Regulatory framework
    • 7.4.4.3. Competitive insights
    • 7.4.4.4. France Endobronchial ultrasound biopsy market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.4.5. Italy
    • 7.4.5.1. Key country dynamic
    • 7.4.5.2. Regulatory framework
    • 7.4.5.3. Competitive insights
    • 7.4.5.4. Italy Endobronchial ultrasound biopsy market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.4.6. Spain
    • 7.4.6.1. Key country dynamic
    • 7.4.6.2. Regulatory framework
    • 7.4.6.3. Competitive insights
    • 7.4.6.4. Spain Endobronchial ultrasound biopsy market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.4.7. Denmark
    • 7.4.7.1. Key country dynamic
    • 7.4.7.2. Regulatory framework
    • 7.4.7.3. Competitive insights
    • 7.4.7.4. Denmark Endobronchial ultrasound biopsy market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.4.8. Sweden
    • 7.4.8.1. Key country dynamic
    • 7.4.8.2. Regulatory framework
    • 7.4.8.3. Competitive insights
    • 7.4.8.4. Sweden Endobronchial ultrasound biopsy market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.4.9. Norway
    • 7.4.9.1. Key country dynamic
    • 7.4.9.2. Regulatory framework
    • 7.4.9.3. Competitive insights
    • 7.4.9.4. Norway Endobronchial ultrasound biopsy market estimates and forecasts, 2021 - 2033 (USD Million)
• 7.5. Asia Pacific
  • 7.5.1. Asia Pacific Endobronchial ultrasound biopsy market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.5.2. Japan
    • 7.5.2.1. Key country dynamic
    • 7.5.2.2. Regulatory framework
    • 7.5.2.3. Competitive insights
    • 7.5.2.4. Japan Endobronchial ultrasound biopsy market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.5.3. China
    • 7.5.3.1. Key country dynamic
    • 7.5.3.2. Regulatory framework
    • 7.5.3.3. Competitive insights
    • 7.5.3.4. China Endobronchial ultrasound biopsy market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.5.4. India
    • 7.5.4.1. Key country dynamic
    • 7.5.4.2. Regulatory framework
    • 7.5.4.3. Competitive insights
    • 7.5.4.4. India Endobronchial ultrasound biopsy market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.5.5. South Korea
    • 7.5.5.1. Key country dynamic
    • 7.5.5.2. Regulatory framework
    • 7.5.5.3. Competitive insights
    • 7.5.5.4. South Korea Endobronchial ultrasound biopsy market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.5.6. Australia
    • 7.5.6.1. Key country dynamic
    • 7.5.6.2. Regulatory framework
    • 7.5.6.3. Competitive insights
    • 7.5.6.4. Australia Endobronchial ultrasound biopsy market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.5.7. Thailand
    • 7.5.7.1. Key country dynamic
    • 7.5.7.2. Regulatory framework
    • 7.5.7.3. Competitive insights
    • 7.5.7.4. Thailand Endobronchial ultrasound biopsy market estimates and forecasts, 2021 - 2033 (USD Million)
• 7.6. Latin America
  • 7.6.1. Latin America Endobronchial ultrasound biopsy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.6.2. Brazil
    • 7.6.2.1. Key country dynamic
    • 7.6.2.2. Regulatory framework
    • 7.6.2.3. Competitive insights
    • 7.6.2.4. Brazil Endobronchial ultrasound biopsy market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.6.3. Argentina
    • 7.6.3.1. Key country dynamic
    • 7.6.3.2. Regulatory framework
    • 7.6.3.3. Competitive insights
    • 7.6.3.4. Argentina Endobronchial ultrasound biopsy market estimates and forecasts, 2021 - 2033 (USD Million)
• 7.7. MEA
  • 7.7.1. MEA Endobronchial ultrasound biopsy market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.7.2. South Africa
    • 7.7.2.1. Key country dynamic
    • 7.7.2.2. Regulatory framework
    • 7.7.2.3. Competitive insights
    • 7.7.2.4. South Africa Endobronchial ultrasound biopsy market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.7.3. Saudi Arabia
    • 7.7.3.1. Key country dynamic
    • 7.7.3.2. Regulatory framework
    • 7.7.3.3. Competitive insights
    • 7.7.3.4. Saudi Arabia Endobronchial ultrasound biopsy market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.7.4. UAE
    • 7.7.4.1. Key country dynamic
    • 7.7.4.2. Regulatory framework
    • 7.7.4.3. Competitive insights
    • 7.7.4.4. UAE Endobronchial ultrasound biopsy market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.7.5. Kuwait
    • 7.7.5.1. Key country dynamic
    • 7.7.5.2. Regulatory framework
    • 7.7.5.3. Competitive insights
    • 7.7.5.4. Kuwait Endobronchial ultrasound biopsy market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Global Level Company Market Share Analysis, 2025 (%)
• 8.2. Company Market Share Analysis at Product Level, by Region, 2025
  • 8.2.1. EBUS Scopes Market Share, 2025 (%)
  • 8.2.2. Ultrasound Processors And Imaging Systems Market Share, 2025 (%)
  • 8.2.3. EBUS -TBNA Needles Market Share, 2025 (%)
  • 8.2.4. EBUS-related Bronchoscopic Biopsy Consumables & Accessories Market Share, 2025 (%)
• 8.3. Company Categorization (Mature players & Emerging players)
• 8.4. Company Market Position Analysis, 2025
• 8.5. Strategy Mapping
• 8.6. Company Profiles/Listing
  • 8.6.1. PENTAX Medical (a division of HOYA Group)
    • 8.6.1.1. Overview
    • 8.6.1.2. Financial performance
    • 8.6.1.3. Product benchmarking
    • 8.6.1.4. Strategic initiatives
  • 8.6.2. Boston Scientific Corporation
    • 8.6.2.1. Overview
    • 8.6.2.2. Financial performance
    • 8.6.2.3. Product benchmarking
    • 8.6.2.4. Strategic initiatives
  • 8.6.3. Olympus America (Subsidiary of Olympus Corporation)
    • 8.6.3.1. Overview
    • 8.6.3.2. Financial performance
    • 8.6.3.3. Product benchmarking
    • 8.6.3.4. Strategic initiatives
  • 8.6.4. Cook Group
    • 8.6.4.1. Overview
    • 8.6.4.2. Financial performance
    • 8.6.4.3. Product benchmarking
    • 8.6.4.4. Strategic initiatives
  • 8.6.5. FUJIFILM Holdings Corporation
    • 8.6.5.1. Overview
    • 8.6.5.2. Financial performance
    • 8.6.5.3. Product benchmarking
    • 8.6.5.4. Strategic initiatives
  • 8.6.6. Medi-Globe Technologies GmbH (Acquired by DCC Healthcare in October 2022)
    • 8.6.6.1. Overview
    • 8.6.6.2. Financial performance
    • 8.6.6.3. Product benchmarking
    • 8.6.6.4. Strategic initiatives
  • 8.6.7. ACE Medical Devices Pvt. Ltd.
    • 8.6.7.1. Overview
    • 8.6.7.2. Financial performance
    • 8.6.7.3. Product benchmarking
    • 8.6.7.4. Strategic initiatives
  • 8.6.8. Praxis Medical
    • 8.6.8.1. Overview
    • 8.6.8.2. Financial performance
    • 8.6.8.3. Product benchmarking
    • 8.6.8.4. Strategic initiatives
  • 8.6.9. CONMED
    • 8.6.9.1. Overview
    • 8.6.9.2. Financial performance
    • 8.6.9.3. Product benchmarking
    • 8.6.9.4. Strategic initiatives